Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4163)
All Articles published online
|
Jul 7, 2008 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shorbagi A, Bayraktar Y. Primary sclerosing cholangitis - What is the difference between east and west? World J Gastroenterol 2008; 14(25): 3974-3981 [PMID: 18609680 DOI: 10.3748/wjg.14.3974] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i25/3974.htm |
| Number | Citing Articles |
| 1 |
Tej I. Mehta, Simcha Weissman, Brian M. Fung, John Sotiriadis, Keith D. Lindor, James H. Tabibian. Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta‐analysis. Liver International 2021; 41(10): 2418 doi: 10.1111/liv.15007
|
| 2 |
Debashree Debasish Das, Nikita Sharma, Pooja A Chawla. Current trends and future perspectives in the treatment of PBC and PSC: A review. Health Sciences Review 2022; 5: 100065 doi: 10.1016/j.hsr.2022.100065
|
| 3 |
Jonathan H. Aron, Christopher L. Bowlus. The immunobiology of primary sclerosing cholangitis. Seminars in Immunopathology 2009; 31(3): 383 doi: 10.1007/s00281-009-0154-7
|
| 4 |
Chalermrat Bunchorntavakul, K. Rajender Reddy. Medical Therapy of Ulcerative Colitis. 2014; : 439 doi: 10.1007/978-1-4939-1677-1_41
|
| 5 |
James H. Tabibian, Christopher L. Bowlus. WITHDRAWN: Primary sclerosing cholangitis: A review and update. Liver Research 2018; doi: 10.1016/j.livres.2017.12.013
|
| 6 |
A Boudewijn de Vries, Marcel Janse, Hans Blokzijl, Rinse K Weersma. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World Journal of Gastroenterology 2015; 21(6): 1956-1971 doi: 10.3748/wjg.v21.i6.1956
|
| 7 |
James H. Tabibian, Christopher L. Bowlus. Primary sclerosing cholangitis: A review and update. Liver Research 2017; 1(4): 221 doi: 10.1016/j.livres.2017.12.002
|
| 8 |
C. Buffet. Cholangites sclérosantes. EMC - Hépatologie 2011; 6(1): 1 doi: 10.1016/S1155-1976(11)50375-4
|
| 9 |
Corma MA Otte, Jan Rothuizen, Robert P Favier, Louis C Penning, Sandra Vreman. A morphological and immunohistochemical study of the effects of prednisolone or ursodeoxycholic acid on liver histology in feline lymphocytic cholangitis. Journal of Feline Medicine and Surgery 2014; 16(10): 796 doi: 10.1177/1098612X14520811
|
| 10 |
G. Martin-Blondel, B. Camara, J. Selves, M.-A. Robic, S. Thebault, D. Bonnet, L. Alric. Étiologies et évolution des hépatites granulomateuses : étude rétrospective de 21 cas consécutifs. La Revue de Médecine Interne 2010; 31(2): 97 doi: 10.1016/j.revmed.2009.10.430
|
| 11 |
Satohiro Matsumoto, Keita Matsumoto, Hiromu Takaya, Haruka Otake, Hirosato Mashima. <p>Efficacy of Ustekinumab Against Spondyloarthritis Associated with Crohn’s Disease: A Case Report and Review of the Literature</p>. Open Access Rheumatology: Research and Reviews 2020; : 133 doi: 10.2147/OARRR.S263259
|
| 12 |
Carles Leal-Valdivieso, Juan E. Naves, Míriam Mañosa, Yamile Zabana, Eduard Cabré, Eugeni Domènech. Hipertensión portal en pacientes con enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2010; 33(4): 297 doi: 10.1016/j.gastrohep.2009.12.003
|
| 13 |
James H. Tabibian, Felicity Enders, Mohamad H. Imam, Gururaj Kolar, Keith D. Lindor, Jayant A. Talwalkar. Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis. Annals of Hepatology 2014; 13(3): 384 doi: 10.1016/S1665-2681(19)30869-5
|
| 14 |
Mohammad Hadizadeh, Seyed H. Abedi, Habib Malekpour, Ebrahim Radinnia, Sayena Jabbehdari, Maryam Padashi, Mohammad R. Zali, Amir H. Mohammad Alizadeh. Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran. Arab Journal of Gastroenterology 2016; 17(1): 17 doi: 10.1016/j.ajg.2015.09.004
|
| 15 |
C.M.A. Otte, L.C. Penning, J. Rothuizen, R.P. Favier. Retrospective comparison of prednisolone and ursodeoxycholic acid for the treatment of feline lymphocytic cholangitis. The Veterinary Journal 2013; 195(2): 205 doi: 10.1016/j.tvjl.2012.06.020
|
| 16 |
Jing Hieng Ngu, Richard Blair Gearry, Andrew Jeffrey Wright, Catherine Ann Malcolm Stedman. Inflammatory Bowel Disease Is Associated With Poor Outcomes of Patients With Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 2011; 9(12): 1092 doi: 10.1016/j.cgh.2011.08.027
|
| 17 |
Carolina Palmela, Farhad Peerani, Daniel Castaneda, Joana Torres, Steven H. Itzkowitz. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. Gut and Liver 2018; 12(1): 17 doi: 10.5009/gnl16510
|
| 18 |
C. Buffet. Manifestations hépatiques et biliaires des maladies inflammatoires chroniques des intestins. EMC - Hépatologie 2012; 7(4): 1 doi: 10.1016/S1155-1976(12)59756-1
|
| 19 |
Mohammad Reza Fattahi, Seyyed Ali Malek-Hosseini, Gholam Reza Sivandzadeh, Ali Reza Safarpour, Kamran Bagheri Lankarani, Ali Reza Taghavi, Fardad Ejtehadi. Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis. Inflammatory Bowel Diseases 2017; 23(7): 1160 doi: 10.1097/MIB.0000000000001105
|
| 20 |
Thomas Greuter, Stephan R. Vavricka. Extraintestinal manifestations in inflammatory bowel disease – epidemiology, genetics, and pathogenesis. Expert Review of Gastroenterology & Hepatology 2019; 13(4): 307 doi: 10.1080/17474124.2019.1574569
|
| 21 |
Hiroyuki Isayama, Susumu Tazuma, Norihiro Kokudo, Atsushi Tanaka, Toshio Tsuyuguchi, Takahiro Nakazawa, Kenji Notohara, Suguru Mizuno, Nobuhisa Akamatsu, Masahiro Serikawa, Itaru Naitoh, Yoshiki Hirooka, Toshifumi Wakai, Takao Itoi, Tomoki Ebata, Shinji Okaniwa, Terumi Kamisawa, Hiroki Kawashima, Atsushi Kanno, Keiichi Kubota, Masami Tabata, Michiaki Unno, Hajime Takikawa. Clinical guidelines for primary sclerosing cholangitis 2017. Journal of Gastroenterology 2018; 53(9): 1006 doi: 10.1007/s00535-018-1484-9
|
| 22 |
Christian Rupp, Anne Mummelthei, Peter Sauer, Karl H. Weiss, Peter Schirmacher, Adolf Stiehl, Wolfgang Stremmel, Daniel N. Gotthardt. Non‐IBD immunological diseases are a risk factor for reduced survival in PSC. Liver International 2013; 33(1): 86 doi: 10.1111/liv.12028
|
| 23 |
B. Eksteen. Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis. British Medical Bulletin 2014; 110(1): 89 doi: 10.1093/bmb/ldu008
|
| 24 |
Josef Finsterer, Sonja Höflich. Successful low-dose azathioprine for myasthenia gravis despite hepatopathy from primary sclerosing cholangitis: a case report. Journal of Medical Case Reports 2010; 4(1) doi: 10.1186/1752-1947-4-356
|
| 25 |
James H. Tabibian, Konstantinos N. Lazaridis, Nicholas F. LaRusso. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 663 doi: 10.1016/B978-0-323-34062-5.00041-8
|
| 26 |
Otranto in the Middle Ages: a Serious Game forthe Edutainment. International Journal of Information and Education Technology 2011; : 47 doi: 10.7763/IJIET.2011.V1.9
|